Biopharma M&A: EY analysts optimistic for 2021 deals after a mixed 2020

EY2
EY published its 2021 M&A Firepower report about the life sciences industry. The report looked back at 2020 trends and started predicting the deals landscape in 2021. Credit: Shutterstock.